TheraRadar
← Back
Data updated: Mar 29, 2026

NATCO

OncologyInfectious DiseaseDermatology
Generics

NATCO is a generic drug manufacturer focused on Oncology, Infectious Disease, Dermatology. Key products include LAMIVUDINE AND ZIDOVUDINE.

1986
Since
23
Drugs
-
Trials
240
Approved (2yr)

Key Drugs

TIPIRACIL HYDROCHLORIDE AND TRIFLURIDINE
tipiracil hydrochloride
· 2023

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 32%
3 drugs Phase 2: 1
Infectious Disease 29%
3 drugs
Dermatology 19%
2 drugs
Gastroenterology 10%
1 drugs
Respiratory 10%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology, Respiratory
Baxter specialty
Infectious Disease, Oncology, Dermatology
Gilead Sciences biotech
Infectious Disease, Oncology, Gastroenterology, Respiratory
EXTROVIS big-pharma
Oncology, Infectious Disease, Dermatology, Respiratory, Gastroenterology